Brief Report: HIV Pre-exposure Prophylaxis Prescribing in an Urban Safety-Net Health System

被引:1
作者
Agovi, Afiba Manza-A [1 ,2 ]
Anikpo, Ifedioranma [1 ]
Cvitanovich, Matthew J. [1 ]
Fasanmi, Esther O. [3 ,4 ]
Ojha, Rohit P. [1 ,2 ]
Marcus, Julia L. [5 ,6 ]
机构
[1] JPS Hlth Network, Ctr Epidemiol & Healthcare Delivery Res, Ft Worth, TX 76104 USA
[2] TCU & UNTHSC Sch Med, Dept Med Educ, Ft Worth, TX 76107 USA
[3] JPS Hlth Network, Pharm Clin Serv Outpatient, Ft Worth, TX USA
[4] JPS Hlth Network, Healing Wings Infect Dis Clin, Ft Worth, TX USA
[5] Harvard Med Sch, Boston, MA 02115 USA
[6] Harvard Pilgrim Hlth Care Inst, Boston, MA USA
关键词
HIV; prevention; pre-exposure prophylaxis; implementation; safety net; UNITED-STATES; MEDICAL HOME; CARE; IMPLEMENTATION;
D O I
10.1097/QAI.0000000000002767
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Introduction: Safety-net health systems are key settings for HIV pre-exposure prophylaxis (PrEP) implementation, but little evidence is available about the frequency of PrEP prescribing in safety-net settings. We assessed PrEP prescribing among people with indications for PrEP at an urban safety-net health system that serves a county designated as an Ending the HIV Epidemic priority jurisdiction. Methods: We identified adults (aged 18 years or older) who engaged in primary care between January 2015 and December 2019 and had a documented indication for PrEP. PrEP indications included the presence of a behavioral or sexual risk factor of HIV acquisition or a positive bacterial sexually transmitted infection at the index visit. PrEP prescribing was defined as the proportion of patients with indications for PrEP who received a new prescription for PrEP. We estimated the cumulative incidence of PrEP prescription with corresponding 95% confidence limits (CL). Results: Our study population comprised 2957 individuals, of whom 58% was aged younger than 45 years, 56% was women, 67% was racial or ethnic minorities, and 60% was uninsured or provided care as part of a hospital-based managed care plan for individuals without insurance. We identified 41 individuals who were prescribed PrEP. The cumulative incidence of PrEP prescribing within 1 year of the first documented PrEP indication was 1.3% (95% CL: 0.91% to 1.7%). Conclusions: Our results suggest extremely low frequency of PrEP prescribing among people with indications for PrEP in an urban safety-net health system. Strategies are needed to improve PrEP implementation in high-priority populations and safety-net settings.
引用
收藏
页码:E17 / E21
页数:5
相关论文
共 50 条
  • [31] Why Do HIV Pre-Exposure Prophylaxis Users Discontinue Pre-Exposure Prophylaxis Care? A Mixed Methods Survey in a Pre-Exposure Prophylaxis Clinic in Belgium
    Vanbaelen, Thibaut
    Rotsaert, Anke
    Jacobs, Bart K. M.
    Florence, Eric
    Kenyon, Chris
    Vuylsteke, Bea
    Laga, Marie
    Thijs, Reyniers
    AIDS PATIENT CARE AND STDS, 2022, 36 (04) : 159 - 167
  • [32] Pre-Exposure Prophylaxis for HIV: Evidence and Perspectives
    Nikolopoulos, Georgios K.
    Christaki, Eirini
    Paraskevis, Dimitrios
    Bonovas, Stefanos
    CURRENT PHARMACEUTICAL DESIGN, 2017, 23 (18) : 2579 - 2591
  • [33] HIV prevention using pre-exposure prophylaxis
    Daou, S.
    Calmy, A.
    REVUE DE MEDECINE INTERNE, 2011, 32 (11): : 658 - 662
  • [34] Pharmacists as providers of HIV pre-exposure prophylaxis
    Bruno, Christine
    Saberi, Parya
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2012, 34 (06) : 803 - 806
  • [35] Ethics and Pre-exposure Prophylaxis for HIV Infection
    Sugarman, Jeremy
    Mayer, Kenneth H.
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2013, 63 : S135 - S139
  • [36] Prescribing pre-exposure prophylaxis in general practice
    Bhatti, Osama
    So, Darren
    Zahid, Muhammad Abdullah
    Cornelisse, Vincent J.
    AUSTRALIAN JOURNAL OF GENERAL PRACTICE, 2021, 50 (07) : 479 - 482
  • [37] Recent advances in pre-exposure prophylaxis for HIV
    Desai, Monica
    Field, Nigel
    Grant, Robert
    McCormack, Sheena
    BMJ-BRITISH MEDICAL JOURNAL, 2017, 359 : j5011
  • [38] Pre-Exposure Prophylaxis Care Continuum for HIV Risk Populations: An Umbrella Review of Systematic Reviews and Meta-Analyses
    Jin, Guifang
    Shi, Haiyan
    Du, Jun
    Guo, Haiyun
    Yuan, Guojing
    Yang, Huayu
    Zhu, Zhihui
    Zhang, Jianghui
    Zhang, Kexin
    Zhang, Xueqing
    Lu, Xiaoyan
    Xu, Wenzhuo
    Wang, Sainan
    Hao, Jiahu
    Sun, Ying
    Su, Puyu
    Zhang, Zhihua
    AIDS PATIENT CARE AND STDS, 2023, 37 (12) : 583 - 615
  • [39] Pre-Exposure Prophylaxis for HIV Infection and the Role of the Women's Health Care Provider in HIV Prevention
    Ruppe, Leah B.
    Spencer, Lisa A.
    Kriebs, Jan M.
    JOURNAL OF MIDWIFERY & WOMENS HEALTH, 2021, 66 (03) : 322 - 333
  • [40] Health Care Provider Perspectives on Pre-exposure Prophylaxis: A Qualitative Study
    Przybyla, Sarahmona
    LaValley, Susan
    St Vil, Noelle
    JANAC-JOURNAL OF THE ASSOCIATION OF NURSES IN AIDS CARE, 2019, 30 (06): : 630 - 638